Atlas Trials

Theophylline for Treatment of Pseudohypoparathyroidism

Clinical trial NCT04240821 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT04240821
Sponsor
Jaclyn Tamaroff
Status
ENROLLING_BY_INVITATION
Phase
Phase 2
Study type
INTERVENTIONAL
PseudohypoparathyroidismPseudohypoparathyroidism Type 1aAlbright Hereditary Osteodystrophy
Start date
2020-05-22
Primary completion
2026-12-31
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.